Filing Details
- Accession Number:
- 0001209191-17-041065
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-20 16:07:47
- Reporting Period:
- 2017-06-17
- Filing Date:
- 2017-06-20
- Accepted Time:
- 2017-06-20 16:07:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816284 | Celgene Corp | CELG | Pharmaceutical Preparations (2834) | 222711928 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1298083 | A Michael Friedman | C/O Celgene Corporation 86 Morris Avenue Summit NJ 07901 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-06-17 | 333 | $0.00 | 0 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-06-19 | 5,000 | $59.06 | 0 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-06-19 | 5,000 | $125.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2017-06-17 | 333 | $0.00 | 333 | $0.00 |
| Common Stock | Common Stock | Disposition | 2017-06-19 | 5,000 | $0.00 | 5,000 | $59.06 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 334 | No | 4 | M | Direct | ||
| 0 | 2023-06-12 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 14,907 | Indirect | Family Trust |
Footnotes
- One-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock.
- These shares were sold by the reporting person pursuant to a Rule 10b5-1 plan.
- The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
- The balance of the restricted stock units will vest on June 17, 2018. Vested shares will be delivered to the reporting person promptly after the vesting date.
- The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the 2008 Stock Incentive Plan (as amended and restated on April 15, 2015)).
- The option was fully exercisable.
- The option was issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the 2008 Stock Incentive Plan (as amended and restated as of April 15, 2015)).
Billionaire Hedge Funds
